Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
2-7-2020 2:30 PM

Analysis of Oxidatively Damaged Proteins by Mass Spectrometry
Vincent Saullo, The University of Western Ontario
Supervisor: Lars Konermann, The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Master of Science degree in
Chemistry
© Vincent Saullo 2020

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Amino Acids, Peptides, and Proteins Commons, and the Analytical Chemistry Commons

Recommended Citation
Saullo, Vincent, "Analysis of Oxidatively Damaged Proteins by Mass Spectrometry" (2020). Electronic
Thesis and Dissertation Repository. 6823.
https://ir.lib.uwo.ca/etd/6823

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

Abstract

As humans age, exposure to oxidative stress may induce protein degradation or aggregation;
both resulting in loss of protein function. Protein oxidative damage remains a dominant
pathology in many common ailments. To combat these pathologies, scientists must understand
the nature of oxidative modifications and their effects on protein structure and dynamics. This
work employs a range of mass spectrometry (MS) methods to characterize and analyze the
effects of oxidative damage on the model protein myoglobin (Mb). Mb was oxidized using
tert-butyl hydroperoxide, and the resulting modifications were characterized by top-down and
bottom-up MS workflows. Hydrogen/deuterium exchange MS indicated elevated structural
dynamics in oxidatively modified regions. Collision-induced activation showed that oxidized
Mb loses heme more readily than its unmodified counterpart. Ion mobility experiments
uncovered that collision-induced unfolding produces more compact non-native gas phase
structures for the oxidized protein. The methods applied provide an analytical foundation for
the comprehensive characterization of oxidative damage that will be applicable to many other
proteins.

Keywords
Protein oxidation, Protein Dynamics, Mass Spectrometry, Reactive Oxygen Species,
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Summary for Lay Audience
Oxidative damage is the result of an overabundance of reactive oxygen-containing chemicals
in the body. These chemicals arise as the result normal cellular processes but can be
exacerbated by external factors like smoking or tanning. Antioxidants in the body combat the
effects of these chemicals, but an imbalance can result in damaging reactions occurring inside
of the body (i.e., oxidative damage). As living things age, deterioration of biological processes
can be partially attributed to accumulation of oxidatively modified proteins – the biological
building block for cells and tissues. Oxidative damage has been implicated as one of the causes
of common ailments including glaucoma and neurodegenerative disorders such as Parkinson’s
and Alzheimer’s disease. Looking into the eyes of someone who suffers glaucoma, the direct
result of oxidative protein damage can be seen. The cloudiness in the eye is produced by the
accumulation of proteins that have lost function due to extensive oxidation, unrepairable by
the body.
This work aims to examine the factors that lead to the disfunction of proteins after oxidative
damage. Working with oxidized proteins poses difficulty because they tend to cause problems
for many conventional analytical methods; one of these difficulties is their non-uniform mass
distribution. Here, we developed a procedure that mimics the effects of reactive oxygen species
in the body. Mass spectrometry (MS), a method involving the characterization of gaseous
protein ions produced by electrospray ionization, proved to be a versatile approach that allowed
us to accurately assess modifications. By applying various MS methods, we were able to
determine the chemical nature of modifications, their locations, and their effects on protein
structure and dynamics. In this way it was possible to obtain valuable information that might
one day help with the development of treatments to combat oxidative damage. Earlier MS
studies have produced valuable information on oxidized proteins but neglected certain methods
due to onerous data analysis. The current work addresses many of these difficulties, thereby
establishing a comprehensive MS-based platform for the characterization of oxidatively
damaged proteins.
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Chapter 1 - Introduction
1.1 Proteins
Proteins are among the key building block of all living organisms. Within the cell, proteins
are responsible for a variety of roles encompassing signaling, catalysis, host defense, and
transport.1,2 Given their diverse functions, fascination with proteins continuously grows,
spanning multiple fields of study that range from basic physical chemistry to clinical
research. Protein misfunction is linked to numerous diseases, creating an urgent need to
better understand the fundamentals of protein structure and dyamics.3–11

1.1.1

Structure

Proteins are assembled by translation of mRNA at a ribosome, resulting in the creation of
a polymeric chain of L-amino acids. Amino acids are composed of three main components:
an amine group, a carboxylic acid group and a chiral -carbon bearing a sidechain (“R”
group). When any two of the 20 possible amino acids bind together, they produce a peptide
bond through the formation of an amide between the carboxylic acid group of one amino
acid and amine group of the next (Figure 1). These peptide bonds exhibit partial double
bond character, forcing the adjacent six atoms into a plane.
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Figure 1: Amide bond formation between two amino acids.
The primary structure (amino acid sequence) serves as a unique identifier of each protein;
this sequence dictates the protein folding behavior and therefore determines the final
protein structure (Figure 2A). The conformational freedom of polypeptide chains arises
primarily from rotation of the dihedral angles  and  on either side of -carbons.12 As the
backbone arranges itself during the folding process, numerous intramolecular hydrogen
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bonds form between backbone NH and CO groups. These hydrogen bonds give rise to two
particularly favorable secondary structures; -helices and -sheets (Figure 2B).13,14
Protein tertiary structures are further stabilized by disulfide bonds, hydrophobic contacts,
salt bridges, and van der Waals contacts (Figure 2C).15,16 Natively folded proteins can also
incorporate organic or inorganic moieties to introduce new functionality. Cofactors, such
as heme, allow many proteins (e.g., hemoglobin, cytochrome c and myoglobin) to perform
functions that go beyond features mediated by amino acid side chains. Quaternary structure
refers to the oligomerization of two or more polypeptide chains into higher order
complexes (Figure 2D). These subunits assemble through intermolecular contacts, forming
complexes with diverse functions.17 Scientists have developed computer programs in an
attempt to predict protein tertiary and quaternary structures (as well as protein function) on
the basis of amino acid sequences. However, such sequence-based prediction algorithms
are still at a relatively early stage of development.18,19
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A)

B)

R-P-P-G-F-S-P-F-R

D)

C)

Figure 2: Different levels of protein structure. A) Primary structure: the sequence of amino
acids building a protein (PDB:6F3V). B) Secondary structure: hydrogen bonds create ordered
structures in terms of -helices (red - PDB:1COS) and -pleated sheets (orange – PDB:1ICL).
C) Tertiary structure: intramolecular side chain interactions produce a folded protein
(PDB:1WLA). D) Quaternary structure: the assembly of multiple amino acid chains and
subunits (indicated by different colour) into a larger structure (PDB:1A3N).
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1.1.2

Protein Dynamics

Seminal studies by scientists such as Kendrew, Ramachandran and Pauling uncovered the
fundamentals of protein structure. However, even the availability of high-resolution X-ray
structures does not necessarily reveal the biological functions of proteins.12,14,20 This is
because protein function is usually not mediated by static structural features (such as those
seen in X-ray crystallography). Instead, the key to understanding protein function lies in
protein dynamics, i.e., structural fluctuations that take place on multiple time scales, from
picoseconds to seconds.1,17 Unravelling how protein conformers dynamically interact with
the surrounding solvent, substrates, and other proteins is essential for understanding
biological systems.
The dynamics of a protein can be visualized as an amalgamation of kinetics and
thermodynamics, where the protein continuously moves through its various Boltzmannallowed conformations on the free energy landscape. Conformations with low free energy
values are thermodynamically preferred, but higher energy states are populated as well
with certain probabilities that scale as exp(-G/RT), where G is the free energy difference
relative to the ground state.21,22 Interactions with ligands can affect the conformational free
energy, thereby either stabilizing or destabilizing various forms.
In enzymes, structural motifs fold into specific catalytically active sites. Dynamic
conformational motions are essential for enzyme-substrate interactions such that active
sites can adopt conformations that are required for catalysis.23,24 The binding of substrates
often produces “induced fit” conformational changes that allow catalytic events to take
place.25,26 Motor proteins exemplify the relationship between dynamics and function
particularly well, as they convert one form of energy into another. For example, F0F1 ATP
Synthase harnesses a proton-motive force to drive the movement of a central rotor, thereby
generating ATP.27–30
Another example is hemoglobin, where the initial binding of O2 to a heme-cofactor induces
a conformational change, as outlined by the Perutz mechanism.31–34 Binding of the first O2
to the heme iron of the completely deoxygenated (T-state) protein induces a conformational
change in the heme porphyrin plane. This event is transmitted via the distal histidine and
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propagates through the entire protein, thereby cooperatively enhancing the favorability of
O2 binding at the remaining three subunits. Eventually, these events produce the fully
oxygenated R-state.35 The binding of effectors can trigger allosteric effects far away from
the effector binding site. For example, effector binding can induce conformational changes
that open or close binding regions elsewhere in the protein, providing the foundation of
various biological regulation effects such as enzyme activation or deactivation.31,36–39
Allosteric interactions are also important for various drug action mechanisms.40,41
Considering how dependent protein function is on conformational dynamics, any factor
that alters the structure and dynamics of the native state will likely be detrimental to normal
function. Oxidative modifications are of paramount importance in this context, as outlined
in the following section.

1.1.3

Protein Oxidative Damage

Protein oxidative damage represents an intriguing physiological phenomenon. Oxidative
stress arises from an imbalance of reactive oxygen species (ROS) relative to antioxidant
defense mechanisms within the body. These imbalances lead to biomolecular damage that
adversely affects cellular functions.42–45 ROS include H2O2, and ROOH, but also free
radicals such as O2•-, •OH, and RO•. These species can arise from both endogenous and
exogenous effects.46 Endogenously, ROS are generated during processes such as cellular
respiration, NADPH oxidase oxidation, and peroxidation.46–50 Exogenous factors such as
smoking and excessive radiation (e.g., tanning, X-rays) also contribute to ROS
generation.46–49 ROS serve important physiological roles. In immune defense, neutrophils
and eosinophils utilize myeloperoxidase and eosinophil peroxidase, respectively, to
produce ROS for combating pathogens.47,51 ROS also serve a role during reversible
oxidation of cysteine and methionine in cell signaling.46,52–55
ROS have been implicated as one of the causes of common ailments including
neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease, and
glaucomatous neurodegeneration.3,49,56–59 As organisms age, deterioration of biological
processes can be partially attributed to accumulation of oxidatively damaged proteisn.4,58,60
The body defends itself against ROS by diverting glucose 6-phosphate (G6P) from
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glycolysis into a side reaction - the pentose monophosphate shunt.50 Here, NADPH is
utilized for the reduction of hydrogen peroxide to water by glutathione (GSH) and catalase
in different reactions. GSH and superoxide dismutase (SOD) both scavenge free radicals,
while catalase breaks down H2O2.44,53,55,61
High concentrations of ROS induce oxidation of lipids and nucleic acids; however, proteins
are the main subject of oxidative damage due to their high abundance,62 often leading to
biomolecular damage that is detrimental to function.42–45 In proteins, ROS mainly target
amino acid side chains (Figure 3), although the backbone is also somewhat susceptible to
modification, in particular by •OH.5,60,63 All these modifications can lead to protein
destabilization, aggregation and loss of function.3,5,49,64

Figure 3: Common oxidative side chain oxidations and their associated mass shifts.
Because of the many deleterious effects of ROS, a large focus has been put on identifying
therapeutically effective antioxidants. Resveratrol (3,5,4’-trihydroxy-trans-stilbene), found
in the skin of grapes, has promising effects in prolonging life expectancy through
modulation of antioxidant metabolism enzymes and scavenging of free radicals.65–69
Protein oxidation alters the physicochemical properties of amino acid side chains such as
mass, charge, shape, and hydrophobicity. These changes, in turn, affect functional

6

7

properties including enzymatic activity and drug binding.1-6,70,62 If an intermediate or
unfolded species becomes oxidized, it may lose its ability to refold to the native state due
to altered intramolecular interactions. As well, natively folded proteins may unfold as a
result of oxidative modifications. Both of these scenarios would most likely result in loss
of function.71–73 If the protein is not subjected to proteasomal degradation and subsequently
replaced, successive oxidation events will lead to the accumulation and/or aggregation of
non-functional protein (Figure 4). For proteins that are not regenerated in the body (i.e.,
crystallin in the eye lens), the effects of ROS are accentuated. Crystallins become resistant
to proteasomal degradation as a result of aging-related oxidative modification and will
accumulate in the eye (cataract formation).71,74,75 Without the ability to repair or regenerate
these proteins, oxidation causes permanent loss of function.74,76

Figure 4: Both native and unfolded proteins may be subjected to oxidative damage when
exposed to ROS. Upon slight oxidation, the protein may maintain its structure but will most
likely be subjected to proteolysis. If oxidation products accumulate, the protein may lose
the ability to exist in a folding equilibrium. The highly oxidized protein loses function and
may become immune to proteolysis, aggregating inside the cell.

1.1.4

Myoglobin

Myoglobin represents a commonly used model system for experimental studies on protein
structure and dynamics.21,77–85 It has a mass of 17.5 kDa and is composed of 8 -helices
(Figure 5).86 In its native state, myoglobin exists as heme-bound holo-myoglobin (hMb) –
granting it function as an oxygen reservoir in muscle tissue. The heme cofactor is contained
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within a hydrophobic pocket where it forms multiple noncovalent linkages, along with a
coordination bond of the iron center to the proximal His93.82 Due to the weak nature of the
heme-protein interactions, myoglobin may also exist in its heme-free apo form (aMb).
Heme loss causes the F helix to partially unfold while leaving the remaining structure
relatively similar to native hMb.77,78,87 In physiologically active hMb the heme is in the
Fe2+ state, but after prolonged oxygen exposure, iron will oxidize to Fe3+. The formation
of metmyoglobin (Fe3+ hMb) is responsible for the brownish-red colour seen in aging red
meat and is unable to bind O2.88,89,90 Increased myoglobin concentration in urine serves as
an indicator of muscle injury and renal failure, while the presence of protein-oxidized
myoglobin in myocardial tissue has been identified to be indicative of acute myocardial
infarction.91–93

Figure 5: X-ray crystal structure of myoglobin from horse heart (PDB 1WLA).

1.2
1.2.1

Classical Methods for Protein Structural Analysis
UV-Vis Spectroscopy

Ultraviolet visible (UV-Vis) absorption spectroscopy uses electromagnetic radiation with
wavelengths in the range of 200 to 700 nm. This method is widely employed for
quantitative assays involving organic, inorganic and biological analytes.94
The Beer-Lambert law (Equation 1.1) establishes the relationship between absorbance (A)
and concentration (c) of a chromophore for a certain path length (l). The molar absorption
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coefficient  is specific to the sample being measured. In Equation 1.1, I0 denotes the
incident light intensity, while I is the intensity of transmitted light.95
𝐴 = 𝑙𝑜𝑔

𝐼0
= 𝜀𝑙𝑐
𝐼

Equation 1.1
UV-Vis spectroscopy is useful for determining protein concentrations by measuring the
absorbance at 280 nm, where the aromatic residues tryptophan, phenylalanine and tyrosine
absorb, or around 407 nm (Soret region) which is the peak absorbance of heme and related
porphyrins.96,97 UV-Vis spectroscopy provides little direct information about protein
structure, however, absorbance changes of cofactors such as heme can report on
conformational changes.

1.2.2

Circular Dichroism (CD) Spectroscopy

CD spectroscopy exploits the differential absorption of left and right-circularly polarized
light by chiral chromophores.98,99 This difference (molar ellipticity) is what constitutes a
CD spectrum. CD spectroscopy is a valuable tool for the analysis of secondary structure.
The absorbance in the far-UV range (180-250 nm) arises from peptide bonds and has
characteristic CD signatures depending on the type of secondary structure (Figure 6).100–
102

In addition, CD in the near-UV range (260-320 nm) caused by absorption by aromatic

amino acids and S-S bonds, is related to their respective environments and reveals tertiary
structural information.98 CD signals can also be associated with cofactors such as heme in
myoglobin or cytochrome c. Although specific secondary structures are not always
accurately quantifiable, changes in CD spectra are a reliable probe of protein folding or
unfolding.
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Figure 6: Different secondary structures produce specific CD spectra.103,104 This figure is
reproduced from reference 103.103

1.2.3

Nuclear Magnetic Resonance (NMR) Spectroscopy

Nuclear magnetic resonance (NMR) spectroscopy is one of the most widely used
techniques for the structural characterization of small chemical compounds. NMR
techniques are based on the absorption of radio-frequency (RF) electromagnetic waves by
atomic nuclei – differing from UV-vis and infrared (IR) spectroscopy which focus on the
outer electrons.94 An externally applied magnetic field aligns spin 1/2 nuclei, with the
magnetic moments being parallel or antiparallel to the field. Once aligned, the absorption
of specific RF frequencies can induce spin flips. The corresponding resonance frequencies
depend on the chemical environment of each nucleus, as governed by the presence of other
nuclei and the surrounding electrons.94,105
Technological advances have drastically improved the ability of NMR spectroscopy to
elucidate the 3D structures of proteins. 2D and 3D NOESY (nuclear Overhauser effect
spectroscopy) techniques - among other methods - and analyzing different nuclei in
addition to 1H, such as

13

C and

15

N, has proven incredibly useful for protein structural

studies. Roughly 10% of the coordinates in the Protein Data Bank (PDB) are NMR
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structures.106–108 NMR is also useful for protein dynamic assays since it can use spin
relaxation measurements for probing conformational fluctuations.108 Currently existing
limitations of protein NMR spectroscopy include its relatively low sensitivity, implying
the need for high analyte concentrations (typically in the high M to low mM range). Some
proteins tend to aggregate under these high concentration conditions. In addition, the
applicability of NMR spectroscopy is typically limited to proteins smaller than ~40 kDa.

1.2.4

X-Ray Crystallography

X-ray diffraction is used for the structure determination of crystallized proteins. Inverse
Fourier analysis of the measured diffraction pattern yields electron densities that can
provide atomically resolved data. For example, John Kendrew solved the structure of
sperm whale myoglobin using X-ray crystallography and was co-awarded the 1962
Chemistry Nobel Prize for this achievement.20 Most of the protein structures in the PDB
were generated using X-ray crystallography. In contrast to NMR spectroscopy, X-ray
methods can be applied to very large proteins, although, crystallization can be challenging
(e.g. for membrane proteins).109

1.3

Mass Spectrometry

Mass spectrometry (MS) characterizes gaseous ions on the basis of their mass to charge
ratios (m/z). MS is revered for its high sensitivity, requiring only small amounts of analyte
at low (M or nM) concentrations. MS can also be paired with complementary analyte
separation and analysis techniques such as UV-Vis absorption, gas chromatography (GC)
and liquid chromatography (LC). Fragmentation cells or ion mobility analyzers can be
added into the mass spectrometer for additional dimensions of analysis.
As MS has matured in recent years, instruments are now available that have a spectral
resolution of over a million (resolution is defined by the peak m/z divided by the width at
50% height). High resolving power affords the ability to distinguish two peaks of similar
m/z from each other, unlocking analysis potential beyond that of just large protein
complexes.110
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Mass spectrometers consist of three main components: ion source, mass analyzer and
detector. One caveat with MS is that analytes must be transformed into gaseous ions. Up
until the 1990s, both of these aspects were problematic for MS analyses of large biological
molecules. Ions generated in the source pass into mass analyzers where they are separated
based on m/z. The ions then reach a detector where they are translated into spectral signals
(ion intensity vs m/z). These components are discussed in detail in the following sections.

1.3.1

Electrospray Ionization (ESI)

Multiple ionization techniques have been developed that can be applied to different types
of samples. These include electron impact (EI), atmospheric pressure chemical ionization
(APCI), chemical ionization (CI), and matrix-assisted laser desorption/ionization
(MALDI). The most widely used method, however, is electrospray ionization (ESI).
Developed by John Fenn,111 ESI in combination with MS has cemented itself as one of the
most effective methods for protein analysis and earned Fenn the Chemistry Nobel Prize in
2002 (jointly with Koichi Tanaka). Briefly, ESI is an ionization technique that involves the
charging of a solution-phase analytes after passing the sample through a charged capillary.
In positive-ion-mode the resulting gas phase analyte ions are normally multiply protonated
with a mass-charge ratio
𝑚 𝑀 + 𝑧(1.008)
=
𝑧
𝑧
Equation 1.2
where M is the neutral analyte mass, z is the number of charges (charge state) and 1.008
represents the proton mass (Da). Greatly improved analytical workflows can be
implemented by coupling high pressure liquid chromatography (HPLC) with ESI-MS for
two-dimensional (solution/gas phase) separations.112 An ESI source in positive ion mode
(Figure 7) resembles an electrochemical cell where the metal capillary represents the anode
and the mass spectrometer inlet is the cathode. Solution is injected either directly or by
HPLC. Charged solution builds up at the tip of the capillary, forming a Taylor Cone. A
mist of charged droplet is emitted from the Taylor cone. These droplets undergo solvent
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evaporation until Coulombic repulsion reaches the surface tension of the solution (a
situation known as “Rayleigh Limit”, defined by Equation 1.3)113

𝑧𝑅 =

8𝜋
√𝜀0 𝛾𝑟 3
𝑒

Equation 1.3
where zR is the droplet charge at the Rayleigh limit, e is 1.60  10-19 C, 𝜀0 is the vacuum
permittivity constant, 𝛾 is the surface tension coefficient, and r is the droplet radius.
Droplets at the Rayleigh limit undergo jet fission. Ultimately, the combination of solvent
evaporation and fission events generates nanometer-sized droplets from which analyte ions
are released into the gas phase.

Figure 7: Schematic depiction of an ESI-source. Analyte solution composed of proteins
(red) and ions enter the source via a charged metal capillary and aerosolize before
reaching the inlet. Droplets decrease in size as solution evaporates.

ESI overcomes the difficulties of working with high-mass proteins as they will become
highly charged, allowing their detection even on mass spectrometers that have limited m/z
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range.114 Ion release from highly charged nanodroplets has long been thought to proceed
via one of two mechanisms; the Charged Residue Model (CRM)115 and the Ion Ejection
Model (IEM).116 Recently, Konermann et al. have proposed an additional pathway, the
Chain Ejection Model (CEM)117 (Figure 8). The CRM applies mostly to globular protein
molecules and states that ESI nanodroplets will dry completely, leaving residual charges
on the globular protein.115 The IEM applies to pre-charged small analytes and ions,
proposing that as droplet size shrinks, the repulsive forces cause ions to eject from the
droplet surface.116 The CEM concerns unfolded proteins and large polymers; it is thought
that hydrophobic surfaces of the analyte will cause the protein chain to migrate toward the
droplet surface. Subsequently, partial ejection of the protein takes place, and charges
equilibrate between the droplet and its protruding tail. The protein then separates from the
droplet in a charge state that is higher than in its folded counterparts.117–119

14
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Figure 8: Overview of ESI mechanisms. a) CRM, b) IEM, c) CEM. For details, see text.

1.3.2

Mass Analyzer

The mass analyzer component separates ions based on their m/z. Different mass analyzers
are available; they serve different purposes and have different performance characteristics
in terms of resolution, transmission efficiency, etc. Common mass analyzers include
quadrupoles, time-of-flight (TOF) analyzers, Fourier transform ion cyclotron resonance
(FTICR) instruments, and Orbitraps. Only quadrupoles and TOF systems will be briefly
discussed.
Mass analyzers can be used to record mass spectra (known as MS1). Alternatively the mass
analyzer can be used for selecting precursor ions with specific m/z which are then
fragmented, followed by fragment ion analysis on a second mass analyzer (MS/MS or
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MS2), the most common fragmentation method is collision-induced dissociation (CID),
which involves the activation of analyte ions via collisions with inert gas atoms. These
collisions cause ion heating, allowing them to overcome activation barriers such that
decomposition can take place. MS/MS data generated in this way provide information on
the structure and chemical composition of analytes, such as the sequence of peptides and
proteins.

1.3.2.1

Quadrupoles

Quadrupoles serve important purposes as ion guides, collision cells and as mass filters for
precursor ion selection. Quadrupoles have a limited mass range and resolution, but they are
well suited for low-mass ions. Quadrupoles consist of four cylindrical rods with applied
electrical potentials, AC (or “radio frequency”, RF) and DC voltage, that allow for selective
transmission of ions. RF/DC ratios remain constant while the amplitude can be varied to
select different m/z ranges. For any given RF/DC ratio, only ions of one specific m/z adopt
a stable trajectory and get transmitted, while other ions become unstable collide with the
rods. Quadrupoles can also be operated as RF-only, where almost all m/z are transmitted.
In this state, the quadrupole can be used as an ion guide or as a collision cell for ion
fragmentation.
Quadrupoles are widely used for precursor ion selection in MS/MS experiments, i.e., prior
to fragmentation in a collision cell. In triple-quadrupole instruments, the second quadrupole
is operated in RF- only mode and serves as collision cell. Quadrupoles can also produce a
mass-spectrum by scanning through different voltages in small steps and measuring ion
output count with a channel electron multiplier. In summary, quadrupoles are highly
versatile, making them a common component of various types of mass spectrometers.

1.3.2.2

Time of Flight Mass Spectrometry (TOF-MS)

TOF mass spectrometers have a flight tube of length l, in which ions are propelled through
a field-free vacuum with a velocity (v) that depends on m/z (Equation 1.4). An electrostatic
pusher applies a uniform orthogonal acceleration voltage pulse ∆𝑈. Subsequently, the
potential energy of the ion (U z e) is converted to kinetic energy (1/2mv2) such that
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𝑙
𝑡𝑓𝑙𝑖𝑔ℎ𝑡

= 𝑣= √

2∆𝑈𝑧𝑒
𝑚

Equation 1.4
Simple linear TOF analyzers have high transmission but low resolution (~2000). Much
higher resolution (20000 and higher) can be obtained on a reflectron-TOF system (Figure
9). Reflectrons act as electrostatic mirrors that reverse the flight direction of ions, based on
electric potentials applied to the stack of rings that constitutes the reflectron. Reflectrons
address the problem that ions of the same m/z can be accelerated to slightly different kinetic
energies in the pusher, thereby causing peak broadening due to different arrival times. The
reflectron corrects for these differences as ions with the same m/z but different kinetic
energy will penetrate the reflectron to different depths, thereby ensuring that the ions reach
the detector after the same time of flight.
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Figure 9: Schematic cartoon of a reflectron-TOF. Ions enter the TOF chamber and are
accelerated with a potential energy, ∆𝑈, applied by the pusher. Ions penetrate the
reflectron to different depths, based on their velocities.
By combining these components, ESI-Q-TOF mass spectrometers (Figure 10) are
commonly used by industry professionals and academics alike. From left to right, an
analyte is ionized via an ESI source and sprayed towards the inlet cone. Ions then
selectively pass through a quadrupole mass analyzer and into the trap where ions may be
fragmented and further separated through an (optional) ion mobility chamber. Passing
through the transfer cell, the ions are given a pulse of energy through the pusher and enter
the TOF flight tube where they are further separated before reaching the detector. For
MS/MS analyses, the quadrupole is used to select specific precursor ions (MS1) for
fragmentation in the trap or transfer cell. The fragments will then be analyzed by the TOF
(MS2) to complete tandem mass spectrometry. The time it takes for an ion to travel from
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the pusher to the detector depends on m/z and is described by rearrangement of Equation
1.4 into Equation 1.5:

𝑚 𝑡𝑓𝑙𝑖𝑔ℎ𝑡 √2𝑒𝑈
=
𝑧
𝑙

√
Equation 1.5

Ions of the same m/z are tallied by the detector to create a mass spectrum with m/z on the
x-axis and counts per second (ion intensity) on the y-axis.

Figure 10: Schematic diagram of a quadrupole-time-of-flight (Q-TOF) mass spectrometer.

1.3.3

Protein Mass Spectrometry

MS has become widely adopted in proteomics and biophysical chemistry due to its
robustness, sensitivity, accuracy, and the versatility offered by different MS workflows.
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Passing the samples through an LC column prior to ESI desalts and purifies analytes,
thereby generating spectra that have high S/N ratios (Figure 11).
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Figure 11: ESI mass spectrum of acid-denatured aMb acquired on a Waters Synapt G2
following HPLC separation. Charge states z of the individual ions are indicated in red.
In addition to providing a mass readout, MS instrumentation has developed to be able to
analyze structure and dynamics, quantify, visualize and identify increasingly complex
samples.110 ESI-MS also has the ability to analyze proteins in their native conformations
using gentle conditions that preserve biomolecular structures and interactions.
One focus area of this thesis is the identification of protein covalent modifications and
assessment of the subsequent effects on protein structure and dynamics. Below, two of the
most common MS methods for identifying such covalent modification are briefly
discussed.

1.3.3.1

Bottom-Up vs. Top-Down Workflows

Two main forms of MS/MS can be distinguished, referred to as bottom-up and top-down
MS. Bottom-up MS employs a protease to digest the protein of interest into peptides prior
to separation on an LC column, with subsequent ESI-MS/MS analysis (Figure 12). Trypsin
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is especially useful for determining protein modifications and structure since it is a
selective protease that only cleaves after lysine and arginine.120,121 However, cleavage
efficiencies can be perturbed by covalent modification of the positively-charged Lys or
Arg side chains.122,123 Bottom-up MS has become standard practice in most MS workflows
because of the dense, site-specific resolution it can provide when coupled to chemical
labelling methods.124,125 In less well-behaved systems, different proteases may be used in
combination to increase digestion efficiency and sequence coverage.

Bottom-Up

Top-Down

CID

MS(/MS)

Figure 12: Both bottom-up and top-down mass spectrometry workflows. In bottom-up, the
protein is digested by a protease (e.g., pepsin or trypsin) to create peptides prior to
separation on an LC column that is coupled to the mass spectrometer. In top-down, the
intact protein enters the mass spectrometer without prior digestion. Instead, the protein is
fragmented in the gas phase.
Rather than employing enzymatic proteolysis, top-down MS involves the fragmentation of
intact protein via application of techniques such as CID, ETD (electron-transfer
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dissociation) or ECD (electron-capture dissociation). In other words, peptides are
generated in the gas phase rather than in solution.126–128 Pairing top-down MS with ion
mobility spectrometry (IMS) delivers better resolved peptides, increasing quality of data.

1.3.3.2

Ion-Mobility Mass Spectrometry

Ion-mobility spectrometry (IMS) is a gas-phase separation technique that analyzes ions
based on their collisional-cross-section (CCS) and their charge. CCS characterizes the
cross-sectional area (i.e., shadow or profile) of an analyte as it passes through the drift tube
interacting with inert gas. IMS offers a complementary dimension of analysis that can
differentiate between isomers and conformers, normally unapproachable with traditional
MS methods.129–131 Combining IMS with LC/MS(MS) provides multidimensional assays
that offer the ability to decipher very complicated analyte mixtures. IMS is commonly used
in the context of screening for illicit drugs and explosives.
IMS involves a drift tube with a homogenous electric field in the presence of a background
buffer gas (Figure 13). The electric field causes the ions to drift, resulting in separation
based on different drift velocities. Cyclic-IMS devices have recently been developed to
achieve unprecedented IMS resolution.132,133
Different types of IMS instruments have been implemented. For example, drift-tube IMS
employs a drift tube with a constant field where analytes are in constant axial motion and
separated based on CCS and drift time.134,135 In contrast, travelling wave IMS (TWIMS)
employs an alternating electrical field (Figure 13). Ions enter the travelling wave ion guide
(TWIG) where axial motion is opposed by a drift gas (e.g., N2). RF voltages on the
electrodes prevent ions from moving in a radial direction, while pulsed DC current moves
ions axially through the opposing drift gas. Because ions only move when acted upon by
the electrical field, TWIMS allows for shorter drift tubes while still achieving
separation.136–139
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Figure 13: Schematic diagram of a travelling wave ion mobility device (TWIMS). Analytes
enter a gas-filled ion guide drift tube and are separated by a pulsating electric field as they
travel toward the detector.

1.4
1.4.1

H/D Exchange Mass Spectrometry
Fundamentals

H/D exchange (HDX) methods are widely used for studying protein structure and
dynamics. Deuterium, 2H, is a heavy isotope of hydrogen that can exchange with hydrogen
atoms in NH/OH/SH bonds.139 This isotopic labelling opens the possibility to an array of
different experiments whereby the difference caused by deuteration can be assessed using
various tools such as NMR or infrared spectroscopy. Most commonly, HDX experiments
are performed with MS detection, and HDX-MS has become a rapidly growing analysis
technique for studying protein folding, dynamics, and interactions.140
Linderstrøm-Lang pioneered the use of HDX for protein analyses in the mid 20th century
when working with insulin.141,142 The possibility of being able to study the single-residue
exchange kinetics by NMR methods was a breakthrough in the 1970s.143,144 Further
breakthroughs came several years later with the advent of multidimensional NMR
methods.145 Today, HDX is dominated by LC-MS-based workflows. LC-MS offers the

23

24

ability for peptide level resolution when paired with an acidic protease such as pepsin,
thereby creating spatially resolved data that reflect dynamic properties of proteins.

1.4.2

HDX Mechanisms

When a protein is fully unfolded and solvent exposed, the N-H → N-D amide hydrogen
transitions take place with a rate constant kch, referred to as the “chemical” rate constant.
Conversely, the N-H → N-D transition in highly ordered regions is tempered by protein
conformation and hydrogen bonds involving the amide hydrogen. These protective factors
cause the deuterium exchange rate constant to fall below that of kch, resulting in an overall
rate constant kHDX (with kHDX << kch). As proteins fluctuate between different allowed
conformations, various short-lived ‘open’ states exist that allow HDX to take place, before
returning to a ‘closed’ conformation. These opening and closing transitions have rate
constants kop and kcl, respectively. Therefore, the overall deuterium exchange mechanism
can be described as

𝑁 − 𝐻𝐶𝑙𝑜𝑠𝑒𝑑

𝑘𝑜𝑝

→
←

𝑘𝑐𝑙

𝑘𝑐ℎ

𝑁 − 𝐻𝑜𝑝𝑒𝑛 𝐷→2𝑂 𝑁 − 𝐷𝑜𝑝𝑒𝑛

𝑘𝑐𝑙

→
←

𝑘𝑜𝑝

𝑁 − 𝐷𝑐𝑙𝑜𝑠𝑒𝑑

146

Equation 1.6
where the HDX rate constant is
𝑘𝐻𝐷𝑋 =

𝑘𝑐ℎ 𝑘𝑜𝑝
𝑘𝑐ℎ + 𝑘𝑐𝑙 + 𝑘𝑜𝑝

Equation 1.7
HDX can take place in two different kinetic regimes, EX1 and EX2.147,148 Simply put, EX1
gives rise to bimodal mass distribution due to complete deuteration of open states prior to
protein refolding (kch >> kcl) such that Equation 1.7 simplifies to

24

25

𝑘𝐻𝐷𝑋 = 𝑘𝑜𝑝
Equation 1.8
In contrast, EX2 shows mass distributions with progressive shifts because deuteration takes
place slower than closing (kcl >> kch). Under these conditions HDX proceeds with a rate
constant
𝑘𝐻𝐷𝑋 = 𝐾𝑜𝑝 𝑘𝑐ℎ
Equation 1.9
where Kop = (kop/kcl) represents the equilibrium constant of bond opening. Figure14
provides a visual representation of these two exchange regimes.

EX2

Time

EX1

Time

m/z

m/z

Figure 14: The EX2 regime (left) describes continuous HDX under conditions where kcl
>> kch. The EX1 mechanism (right) applies if kcl << kch giving rise to bimodal deuterium
uptake distributions.
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HDX is initiated when proteins are exposed to a D2O-based labelling buffer. This step can
happen by exposing the sample to a perturbing agent for a brief amount of time before
pulsing with D2O and quenching (pulse labelling). Alternatively, a protein can be
continuously incubated in labelling buffer, while aliquots are taken at specific time points
(continuous labelling).151 Depending on the type of information desired, local
(peptide/residue level) or global (intact protein) analysis can be conducted by using either
MALDI-MS or LC-MS.
Interaction with HDX buffer causes exchange of labile hydrogens in the amide backbone
and in side chains.141 Side chain deuterium is lost during reverse-phase LC, but backbone
amide deuterium can be mostly retained and analyzed by ESI-MS.152–154 HDX rates depend
on pH and temperature, as well as flanking side chains.146,153–155 This implies that it is
imperative to control experimental factors such as pH, quenching temperature, LC and
column temperature.156 Exchange is slowest at pH ~2.5 where kch attains its minimum
(Figure 15) between acid, base and water catalysis (Equation 1.10) thus presenting an
optimum range for quenching and analysis.96, 97

𝑘𝑐ℎ = 𝑘𝑎𝑐𝑖𝑑 [𝐻 + ] + 𝑘𝑏𝑎𝑠𝑒 [𝑂𝐻 − ] + 𝑘𝑤 [𝐻2 𝑂]
Equation 1.10
The dependence on temperature can be approximated by the Arrhenius equation
𝐸𝑎

𝑘𝑐ℎ = 𝐴𝑒 −𝑅𝑇
Equation 1.11
where A is a constant pre-exponential factor, Ea is activation energy, R is the gas constant
and T is the temperature.158 Hence, HDX quenching is performed by lowering the solution
temperature to ~0 C, in conjunction with acidification. The quenched samples can then be
stored in liquid nitrogen prior to analysis.
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Figure 15: Dependence of kch on pH, revealing the existence of a global minimum at
around pH 2.4-3. This presents the pH used for HDX quenching.157 This figure is
reproduced from reference.157

1.4.3

HDX Data Analysis

HDX-MS is usually performed in a bottom-up fashion.159 In these experiments, a protease
(usually pepsin) is used to create peptide fragments from a protein after HDX, resulting
spatially-resolved data. Top-down HDX-MS represents an alternative workflow that uses
gas phase fragmentation of proteins without prior proteolysis, but this approach is less
commonly applied.160 In this thesis we will focus exclusively on continuous bottom-up
HDX-MS.
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Although efforts are made to minimize back exchange during LC, some level of deuterium
loss is unavoidable. To account for these effects, two control measurements are performed
in addition to the “regular” HDX time points. m100 represents a fully deuterated sample,
and m0, which represents an ambient baseline of deuteration under quenched conditions.
The equation for percentage of deuteration (Dt) for any time point (t) is then calculated as
𝐷𝑡 =

𝑚𝑡 − 𝑚0
× 100%
𝑚100 − 𝑚0

Equation 1.12
where m represents the observed centroid mass of the peptide.161,162 Generally, Dt will be
presented as a function of exposure time for individual peptides. Creating and comparing
uptake plots and superimposing the results on protein PDB structures using a colour
gradient can help visualize uptake differences. The effects of oxidative damage can then
be rationalized relative to structural influences or other factors.
If desired, the amides in any given peptide can be described experimentally by fitting the
HDX profiles to a tri-exponential expression. This involves characterizing all the different
amides and their kHDX values via average values according to fast (N1), medium (N2) or
slow (N3) 146,161,163
𝐷𝑡 = 𝑁1 [1 − 𝑒 −𝑘1𝑡 ] + 𝑁2 [1 − 𝑒 −𝑘2𝑡 ] + 𝑁3 [1 − 𝑒 −𝑘3𝑡 ]
Equation 1.13
However, depending on the kinetic behavior observed, single or double exponential
expressions may be suitable as well.
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1.5

Scope of Thesis

To better understand effects of oxidative damage, the current work focused on Mb as a
simple model protein. We tested the effects of various oxidants including H2O2,
chloramine-T, and tert-butyl hydroperoxide (TBHP) to identify reaction conditions in an
effort to produce relatively homogenous reaction products that could then be interrogated
by a range of MS-based analytical workflows (including LC-MS/MS, HDX-MS, and
IM/MS). TBHP was identified as the most suitable reagent to produce a controlled
oxidation product; minimizing unoxidized fraction and products of overoxidation. Previous
studies in the literature165,166 suggested TBHP to be a methionine specific oxidizing agent;
however; through the rigorous bottom-up and top-down testing of this project, we
debunked this notion.
A key challenge to HDX-MS experiments with oxidized protein is the occurrence of peak
broadening and peak splitting. These phenomena interfere with spectral data analysis, as
most ROS produce a heterogeneous mix of oxidized proteoforms. For this reason, the
application of HDX-MS to oxidized protein has been avoided by other laboratories, leaving
a gap of information regarding pathologically relevant systems. This work aims to begin
closing existing literature gaps through the rigorous structural analysis of the model
protein, Mb, after oxidation. By aiming to overcome the challenges associates with HDXMS of oxidized samples, this work sheds light upon the efficacy of the method in depicting
dynamic alterations, secondary to covalent modification. By demonstrating analyses using
a protein that is only specifically modified in a few known sites, further works may assess
additive effects of further oxidative-damage events, leading up to the point of aggregation.
The combination of various analytical approaches in this work may serve as an outline for
further studies on other oxidatively damaged proteins that are relevant for key pathological
pathways.
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2

Analysis of Oxidatively Modified Myoglobin
Complementary Mass Spectrometry Techniques

by

2.1 Introduction
As humans and other organisms age, oxidatively damaged proteins can accumulate in the
body as the result of encounters with ROS. Oxidative damage contributes to a range of agerelated pathologies, as modified proteins may exhibit impaired function.1–4 This poses
particular risks to tissues where proteins are not continuously regenerated. The brain is
especially susceptible to oxidative damage due to its high demand for oxygen, leading to
various pathologies as discussed in chapter 1.1.3.5
Protein oxidation (in particular, carbonyl formation) has long been viewed as a hallmark
for measuring the extent of oxidative stress and damage to cells.6–11 Quantification can be
achieved through a variety of methods such as OxyBlots, derivatization with 2,4dinitrophenylhydrazine, antibody tagging, and covalent labelling with reagents such as
Girard’s reagent and biotin hydrazide.8,9,12,13 Alternatively, MS lends itself as an
exceptionally sensitive tool for the identification and quantification of oxidative
modifications. As outlined in Chapter 1, protein function is governed by protein structure
and dynamics.14–17 Studying the effects of oxidative damage on protein structural dynamics
is therefore imperative for the development of treatments to combat oxidation-induced
pathologies.
MS offers a number of avenues to probe protein oxidation. Traditional LC-MS/MS bottomup workflows are widely used, but they may yield incomplete information due to protease
inefficiency as a result of oxidative modifications. Top-down MS can potentially overcome
this hurdle, yielding residue-resolved information regarding the exact nature of oxidation
events. IM-MS can provide additional insight, probing the effects of oxidative
modifications on the gas phase structures (CCS) of proteins. Of particular interest is the
ability to acquire information on conformational dynamics with high spatial resolution by
using HDX-MS.18–20 Surprisingly, this particular technique is under-utilized when it comes
to the characterization of oxidatively modified proteins. Possible reasons for the scarcity
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of HDX-MS data in this context include the complexity of the samples, as well as the
cumbersome data analysis and sample conditioning. The current work aims to overcome
some of these complications in pursuit of comprehensive protein analysis.
As discussed in 1.1.3, protein oxidative damage typically results from oxygen-based
radicals and other ROS. One of the main biological sources of radicals is the production of
hydroxyl radical by metal catalyzed oxidation of H2O2, otherwise known as Fenton
Chemistry (Scheme 1, below).21–23 Heme proteins such as Mb, hemoglobin and various
cytochromes can be the source of the Fe2+/3+ required for these processes.
𝐹𝑒 2+ + 𝐻2 𝑂2 → 𝐹𝑒 3+ + 𝐻𝑂• + 𝐻𝑂−
𝐹𝑒 3+ + 𝐻2 𝑂2 → 𝐹𝑒 2+ + 𝐻𝑂𝑂• + 𝐻 +
________________________________________________________________________
2𝐻2 𝑂2 → 𝐻𝑂• + 𝐻𝑂𝑂• + 𝐻2 𝑂

Scheme 1: Formation of oxygen-based radicals from H2O2 via Fenton Chemistry.
The high second order reaction constants for the reaction of peroxide radicals with protein
side chains results in low specificity and reproducibility, because the ROS produced in this
way cause a wide range of different protein modifications.10,23 The non-uniform and highly
heterogeneous nature of the oxidation products generated by these processes makes their
analytical characterization very difficult. For initial method development, it would be
desirable to use an oxidant that is more targeted and that produces relatively homogeneous
oxidation products. For this reason, we did not focus our attention on H2O2, but instead
explored alternative options.
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Figure 1: Chemical structure of hydrogen peroxide (top) and tert-Butyl hydroperoxide
(TBHP - bottom)
TBHP (Figure 1) has been reported by Keck to be a methionine-specific oxidizing agent,
targeting solvent exposed methionine residues in native recombinant interferon  (rIFN-)
and recombinant tissue-type plasminogen activator (rt-PA).24 Similarly, experiments by
Imiołek et al. on Mb yielded promising results that indicated specific methionine oxidation
by TBHP.25 Similar to H2O2, TBHP is susceptible to oxy and peroxide radical formation
via Fenton chemistry. (CH3)3COO• and (CH3)3CO• can be produced in situ at heme iron
centers as outlined below:
𝐹𝑒 2+ + (𝐶𝐻3 )3 𝐶𝑂𝑂𝐻 → 𝐹𝑒 3+ + (𝐶𝐻3 )3 𝐶𝑂• + 𝐻𝑂−
𝐹𝑒 3+ + (𝐶𝐻3 )3 𝐶𝑂𝑂𝐻 → 𝐹𝑒 2+ + (𝐶𝐻3 )3 𝐶𝑂𝑂• + 𝐻 +
________________________________________________________________________
2 (𝐶𝐻3 )3 𝐶𝑂𝑂𝐻 → (𝐶𝐻3 )3 𝐶𝑂• + (𝐶𝐻3 )3 𝐶𝑂𝑂• + 𝐻2 𝑂

Scheme 2: Formation of oxygen-based radicals from TBHP via Fenton Chemistry.
Due to the inherent steric obstruction of tert-butoxyl radicals, second order rate constants
are lower than those of hydroxyl radicals, thereby promoting the formation of oxidation
patterns that are more straightforward. The reported selectivity and reproducibility of
TBHP 24,25 makes this reagent a promising model compound for the experiments of this
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work, and it was therefore used in our experiments for inducing protein oxidative
modifications.
Instead of studying actual in vivo protein oxidation, the current work employed Mb as a
model system to examine the effects of TBHP exposure in vitro. We relied on the presence
of heme iron in Mb to induce Fenton chemistry which causes oxidative damage of the
protein. The oxidized Mb generated in this way then served as a testbed to adapt and
optimize a comprehensive set of MS-based workflows for characterizing the effects of
protein oxidation in solution and in the gas phase.

2.2
2.2.1

Methods
Materials

BioUltra ≥ 98% (SDS-PAGE) hMb from equine skeletal muscle, Luperox® TBH70X
(tert-Butyl hydroperoxide solution – TBHP), Girard’s Reagent T (GRT, carboxymethyltrimethylammonium-hydrazide chloride), and D2O were sourced from Sigma Aldrich (St.
Louis, MO). HCl was purchased from Caledon (Georgetown, ON, Canada). LC-MS grade
H2O was acquired from Optima (Fair Lawn, NJ). Trypsin Gold, mass spectrometry grade,
was obtained from Promega (Madison, WI). All pH values were measured with a Fisher
(Waltham, MA) AB15 pH meter.

2.2.2

Protein Oxidation

Each TBHP-oxidized protein sample was prepared by creating a solution containing 100
M myoglobin, 40 mM pH 6.0 ammonium acetate buffer and 2500 M TBHP oxidant.
The samples were immediately placed on ice once mixed and left to react for 60 minutes,
in accordance with reference 25.25 The reaction was quenched by dialysis in 10 kDa
MWCO filters via a 13 g, 15-minute centrifugal spin-down, repeated three times. Control
protein was prepared under identical conditions, except an equivalent volume of water was
added in place of TBHP oxidant.
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2.2.3

Isotopic Modelling

Protein Prospector is a software package created by the University of California at San
Francisco where isotopic mass distributions are calculated based on chemical composition.
Theoretical mass distributions were normalized and plotted against experimental data to
model spectra accordingly.

2.2.4

Tryptic Digestion

Digestion samples were prepared using Trypsin Gold, 20% acetonitrile, pH 7.7 ammonium
bicarbonate 12.5mM, and 1:20 protein:protease, incubated at 37ºC for 24h. The samples
were quenched with 2.5% formic acid. Waters reverse phase nanoACQUITY UPLC
separation employed a BEH 1.7 m, 1  100 mm C18 column, prior to MS/MS (MSE)
analysis. Waters ProteinLynx Global SERVER is the main data interpretation suite for
Waters instruments and was used to decipher and match MSE data to database values for
tryptic myoglobin peptides, where covalent protein modifications can be accounted for. All
LC-MS peaks were then manually analyzed to confirm any reported peptides to avoid false
positives and negatives.

2.2.5

Covalent Labelling of Oxidatively Modified Protein

Control and oxidized protein stocks were added to a 400 L solution containing 80 mM of
Girard’s reagent T (GRT), 10 M protein, and 50 mM pH 7.4 phosphate buffer. The
samples were incubated at room temperature overnight. To affix the GRT tag, the
hydrazone bond was reduced using excess sodium borohydride on ice for 1 h.26,27
Following, the reaction was quenched by dialysis in 10 kDa MWCO filters via a 13 g, 15minute centrifugal spin-down repeated three times.

2.2.6

Top-Down CID-IM-MS

Experiments were performed on a Synapt G2-Si ESI quadrupole-time-of-flight instrument
set to resolution mode. The instrument parameters were set as follows: cone voltage 20 V,
ESI voltage 2.8 kV, source temperature 80 ºC and desolvation temperature 250 ºC. 10 M
protein samples were prepared in 50:50 H2O:ACN with 0.1% formic acid, and infused
directly by way of a syringe pump, flowing at 5 L/min. MS/MS experiments by collision-
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induced-dissociation (CID) utilized argon collision gas using 27 V to fragment quadrupoleselected 25+ protein ions. IMS separation following fragmentation was performed in N2
buffer gas with corresponding wave velocity of 350 m s-1 and wave height of 13 V.

2.2.7

HDX/MS

A 1000 L HDX samples were prepared containing 89% v/v D2O, 50 mM potassiumphosphate buffer and 5 M protein. 100 L aliquots were taken from this stock at specific
time intervals and quenched in sample tubes containing chilled hydrochloric acid to a
predetermined pH of 2.5 and immediately flash frozen in liquid nitrogen. m0 samples were
used to present a baseline for deuterium uptake by exposing the protein to deuterium buffer
under pre-quenched conditions. These samples were created mimicking the composition
of prior 100 L aliquot time interval samples, in that m0 samples were composed of 89%
v/v D2O, 5 M protein, 50 mM potassium-phosphate buffer and sufficient hydrochloric
acid to reach pH 2.5. m100 samples, which represent fully deuterated protein, were left to
incubate overnight at 40 C. At pH 2.5, m100 samples represent maximum experimental
uptake of denatured protein.

Prior to injection, each frozen sample was rapidly thawed to ~ 0 ºC. Bottom-up HDX-MS
was performed using a nanoACQUITY UPLC equipped HDX Manager, mated to a Synapt
G2 ESI quadrupole-time-of-flight mass spectrometer (Waters, Milford, MA). Online
digestion was performed at 15 ºC using a 2.1 mm  30 mm POROS pepsin column (Life
Technologies/Applied Biosystems, Carlsbad, CA). After passing into the 0 ºC HDX
chamber, the eluent becomes trapped on a BEH C18, 1.7 m, 2.1  5 mm guard column.
For desalting and peptide separation, a 20 min water/acetonitrile (0.1% formic acid)
gradient through a reverse-phase BEH 1.7 m, 1  100 mm C18 column was employed. The
instrument parameters were set as follows: cone voltage 20 V, electrospray voltage 3 kV,
source temperature 80 ºC and desolvation temperature 250 ºC.
MSE data processing and peptide identification were preformed through Waters PLGS
2.4.3. Peptide matches were manually vetted to ensure accuracy before employing Waters

49

50

DynamX 3.0 for analysis of HDX profiles. All experiments were performed in triplicates
but due to the nature of some oxidized samples, a few time points were poorly matched by
DynamX and deemed extraneous. Error bars are representative of the standard deviation
between replicates.

2.2.8

Collision Induced Unfolding - IMS

Experiments were performed on a Synapt G2-Si ESI quadrupole-time-of-flight instrument
set to sensitivity mode. The instrument parameters were set as follows: cone voltage 5 V,
electrospray voltage 2.8 kV, source temperature 25 ºC and desolvation temperature 40 ºC.
10 M protein samples were prepared in pH 7.4, 10 mM ammonium acetate, and infused
directly by a syringe pump, flowing at 5 L/min. IMS was performed in N2 buffer gas with
corresponding wave velocity of 350 m s-1 and wave height of 13 V. CCS values were
calibrated using a mix of denatured and collisionally activated proteins in 49:49:2 (v/v/v)
methanol/water/acetic acid.28 CCS were recorded for the native 9+ protein ion. Collision
energy (using argon gas) was incrementally increased stepwise beginning at 0 V,
proceeding through default instrument settings of 4 V trap and transfer and increasing
steadily inside of a resolvable IMS range.

2.2.9

Collision Induced Dissociation

Experiments were performed on a Synapt G2-Si ESI quadrupole-time-of-flight instrument
set to sensitivity mode. The instrument parameters were set as follows: cone voltage 5 V,
electrospray voltage 2.8 kV, source temperature 25 ºC and desolvation temperature 40 ºC.
10 M protein samples were prepared in pH 7.4, 10 mM ammonium acetate, and infused
directly by way of a syringe pump, flowing at 5 L/min. Native 9+ protein ions were
quadrupole-selected and subjected to incrementally increasing collisional energy inside the
trap cell. Transfer collision energy was held constant at 4 V for every measurement outside
of the initial step where all collision energy was turned to 0 V.
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2.3
2.3.1

Results and Discussion
Oxidation of Myoglobin

Fenton chemistry is a common in vivo and in vitro oxidation mechanism, where iron ions
catalyze the formation of highly reactive oxygen-based radicals from peroxides (Schemes
1, 2).3,6,9,10,23 In heme-containing proteins such as myoglobin, hemoglobin, and cytochrome
c, iron from the porphyrin ring can catalyze these processes.29–38
The initial goal of this work was to create a workflow that would generate Mb oxidation
products that would be relatively simple to characterize. Our primary aim was to attain full
conversion to oxidized species, and secondly, minimize side reactions such that relatively
homogeneous oxidation products would be obtained. Hydrogen peroxide (H2O2) is a wellestablished oxidizing reagent; however, the high second order rate constant causes very
low selectivity, increasing the complexity of the resultant products.23,39–43 Hence, after
acquiring some preliminary data (not shown) we abandoned the use of H2O2 for the current
work. Next, we tested chloramine-T as an oxidizing agent. However, problems were
encountered with this reactant as well; we could not attain full conversion to oxidized
protein without incurring overoxidation and numerous different peaks (data not shown).
Ultimately, we settled on TBHP. This oxidant proved most effective in reproducible Mb
oxidation, achieving a high level of conversion while avoiding overoxidation. TBHP
oxidation of Mb resulted in mass distributions that were dominated by one prominent peak
(Figure 2B, Peak 2) with two lower-abundance subspecies (annotated as Peaks 1 and 3 in
Figure 2B). The notations “Peak 1”, “Peak 2”, and “Peak 3” will be used throughout the
text to identify which species is being referenced. Without proper scrutiny, it would appear
that oxidation with TBHP did not achieve full conversion, as a seemingly unoxidized
fraction remained in the spectrum (Peak 1). However, closer inspection and isotopic
modelling showed that Peak 1 is actually shifted -2 Da relative to the unmodified protein.
Fine isotopic structure overlap comparing Peak 1 to unoxidized control myoglobin (Figure
2C) accentuates the difference between the two species.
A -2 Da mass shift could be the result of disulfide bond formation, carbonylation
of alcohols, dityrosine formation, or a combination of two -1 Da lysine carbonylation
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events.9,39,42–44 All of these outcomes were initially considered; however, since equine
skeletal myoglobin contains no cysteine, disulfide bond formation is impossible. Similarly,
the presence of only a single tyrosine (Y103) precludes the formation of dityrosine.45
Peak 2 was shifted +14 Da relative to control. Although unlikely by Fenton-based
TBHP oxidation,9,39 +14 Da modifications could result from aliphatic carbonylation at
leucine, alanine and valine residues, or oxidation of tryptophan to oxolactone.46
Considering the low likelihood of +14 Da covalent modification, it is more probable that
Peak 2 is composed of the modifications causing the -2 Da shift in Peak 1 and a more
common +16 Da modification (e.g., at methionine, tyrosine, or tryptophan). Peak 3 is the
culmination of further +16 Da and -1 Da modifications, relative to Peak 2. Peak 3 and
additional peaks are too low abundance and too broad for accurate characterization at this
time, so the main focus of this work remained on Peaks 1 and 2.
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Figure 2: A) Mass spectrum of unmodified Mb, with overlaid isotopic model, CS 25+. B)
Mass spectrum of TBHP-oxidized Mb. The spectrum shows three main peaks (1, 2, 3),
dominated by a +14 Da species (Peak 2). Peak 1 corresponds to a -2 Da shift. C) Overlay
of isotopic structure of unoxidized (control) Mb, and Peak 1 of oxidized Mb.
The occurrence of Fenton chemistry under the conditions used here implies that reactive
radicals will be created adjacent to the heme group. For this reason, residues close to heme
are most likely to experience covalent modification. The most probable amino acids to be
oxidized based on proximity to heme and propensity of oxidation are highlighted in Figure
3.9 These include Tyr103, and Lys96. Other residues non-proximal to heme that readily
oxidize are also highlighted.9 These residues are Lys 56, Lys 102, Met55, Met131, Trp7,
and Trp14.
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Figure 3: X-Ray crystal structure of Mb (pdb code 1wla). Residues in close proximity to
heme that are likely to be oxidized. The zoomed in panel on the right highlights the
proximity of heme to K96 and Y103, as well as proximity of Y103 to peptide 30-40. Colours
are used to indicate sites of interest. Yellow: potential sites of -1 Da Lys oxidation. Red:
site of +16 Da Tyr-oxidation. Blue: other residues of various interests i.e., potential
oxidation targets (pictured left), spatial proximity to oxidized sites (pictured right).
Even without a detailed analysis of oxidation sites, the mass distributions seen in Figure 2,
contain at least three reaction products, clearly highlighting the fact that Mb oxidation by
TBHP is not a simple process that only affects Met residues (Mb possesses two Met in
positions M55 and M131). The unexpected complex oxidation pattern seen here is in stark
contrast to the findings of references 24 and 25, which painted a much simpler picture.
Additional complexities became apparent when analyzing the mass distributions of the
oxidized protein under denaturing ESI conditions. Traditional ESI-MS analyses commonly
assume that all charge states under these conditions represent the same mass distribution.47
Surprisingly, the samples studied here show a very different behavior. To assess the sample
variability over different charge states, Figure 4A overlays all charge states in the ESI
spectrum of TBHP-oxidized Mb. For higher charge states, the abundance of Peaks 1 and 3
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is increased relative to Peak 2. Furthermore, low charge states appear shifted to the left,
indicating the possibility of additional oxidative modifications. Figure 4B averages all the
spectra derived from the individual charge states and produces an overall distribution that
still shows Peak 2 as the most abundant signal with a mass increase of roughly +14 Da.
Lower charge states show increasing extent of lysine oxidation (-1 Da) and therefore appear
slightly left shifted. The higher charge states show very similar, overlapped mass profiles.
The intensity of Peak 2 begins to decrease relative to Peaks 2 and 3, as charge state
decreases.
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Charge State Deconvolutions - Overlayed
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Figure 4: A) Deconvoluted mass distributions of various Mb charge states plotted on a
mass axis. B) Average mass distribution generated by summing the data from panel A.
Peak 1 averages to a roughly -2 Da shift, and Peak 2 averages to about +14 Da, relative
to the unmodified control.

2.3.2

Characterization of Oxidative Modifications by Bottom-Up
MS

Being the gold standard of bottom-up proteomics, trypsin digestion is often the first step in
identifying covalent modifications. Both the control (Figure 5A) and oxidized (Figure 5B)
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were digested under identical conditions but produced different LC chromatograms.
Trypsin selectively cleaves after arginine and lysine due to their positive charge; if these
sites become modified and lose their intrinsic charge, the enzyme will not cleave.48 Figure
5 highlights the significant depletion of two peptides, 97-102 and 103-118, and minor
depletion of 51-56, suggesting covalent modification of lysines K56, K96 and K102. This
assay was unable to confirm the presence of lysine modifications as the corresponding
missed-cleaved peptides were not apparent. Due to peak broadening in the oxidized
chromatogram, data analysis software PLGS (Waters) and PEAKS (BSI) returned many
false-positives and inaccurate sequence coverage. This prompted us to perform manual
analyses of all the spectra. The emergence of a new chromatographic peak raised the
possibility of incomplete digestion due to protein aggregation and/or crosslinked products
as the MS and MS/MS data did not match any known or modified Mb peptide, even when
using de novo workflows. We found no modification at either methionine (M55 and
M131), thereby debunking previous claims by Imiołek et al. (see their Figure S8c)25
regarding the purported selectivity of TBHP toward methionine under the exact conditions
used in this experiment. Similarly, Keck24 had claimed that TBHP would specifically
oxidize surface methionine residues although that author did not use Mb for his study. Our
results did not uncover any +14 Da or +16 Da modified peptides, even with ~95% coverage
of the oxidize protein. This suggests that the main modifications comprising Peak 2 must
be located within the residues that were not covered in our experiments (97-102) or the
peptides that were significantly depleted (51-56, 97-102, 103-118).
Alternative proteases including Glu-C and chymotrypsin were also used in an attempt to
further characterize oxidized Mb samples but resulted in far worse coverage and no
additional information relative to trypsin alone.
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Figure 5: A) LC/MS total ion chromatogram of a Mb tryptic digest (unmodified control),
displaying complete digestion and 100% coverage. B) LC/MS total ion chromatogram of
a Mb digest after oxidizing the protein with TBHP. Note the reduced digestion efficiency.
Tryptic peptides 97-102 and 103-118 show significant depletion after oxidation indicating oxidative modifications in those regions. C) Tryptic peptide coverage map.
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2.3.3

Covalent Labelling of Oxidized Mb with GRT

To test the possibility of lysine carbonylation to aminoadipic semialdehyde, covalent
labelling with Girard’s reagent T (GRT) was used. GRT labelling forms products with a
distinct mass shift of +116 Da (after reduction of the imine double bond).26,27,49,50 Figure
6A shows the absence of GRT labels on unoxidized control Mb, after sufficient exposure.
Figure 6B shows the TBHP-oxidized Mb sample prior to any GRT exposure. Figure 6C
confirms the presence of carbonylated species present in Peaks 2 and 3, as resultant GRTtagged species appear +116 Da downstream once oxidized Mb is sufficiently exposed to
GRT. The GRT tagged peaks that resulted from Peak 1 covalent labelling unfortunately
became shadowed by the heightened baseline. Peaks 1 and 2 appeared significantly
depleted and shifted by +2 Da, confirming that most of the species composing these peaks
were lysine carbonylated. This pattern also reaffirms our initial suspicion that Peak 2
comprises a +16 Da oxidation instead of a genuine +14 Da modification.
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Figure 6: Mass spectra of Mb, CS 23+, after labeling with Girard’s reagent T (GRT). A)
Control Mb only shows signals corresponding to the unmodified protein. B) TBHP oxidized
Mb, before GRT exposure. C) Mb after exposure to GRT and bond reduction. Two new
species are present in panel C, arising from the presence of a carbonyl group after TBHP
exposure by the addition of a GRT group (+114 Da GRT, +2 Da bond reduction). Peaks 1
and 2, previously -2 Da and +14 Da respectively relative to control have both shifted +2
Da to the right, indicating the tagging of oxidized Lys by GRT.
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2.3.4

Characterization of Oxidized Mb by Top-Down CID-IM/MS

When proteolytic activity is compromised, as is the case for the scenario encountered here,
the efficiency of bottom-up methods is limited. By combining bottom-up and top-down
workflows and datasets, better characterization and even residue level resolution can be
ascertained. Top-down CID-IM/MS goes beyond conventional MS/MS workflows by
using ion mobility to separate fragments created by CID, adding another dimension of
analysis and increasing effective resolution. Both control and oxidized myoglobin (Peak 2)
samples were analyzed by CID-IM/MS and the resultant fragments were isotopically
modelled (Figure 7). Direct comparison of b and y fragment ions originating from
unmodified Mb and from the oxidized protein then reveals mass shifts that are diagnostic
of specific covalent modifications.
The first key finding from the data set were multiple unmodified fragments: y28-25, y23
and y22. This observation confirms the previously established finding (chapter 2.3.2) that
M131 shows no oxidation and is not the primarily oxidized residue in Peak 2. The second
major finding was the region of overlap encompassing fragments: b68, 69, 71 and y83-81.
Each of the b ions show only a -1 Da shift relative to control while each of the y ions in
this segment show a +15 Da overall shift. This finding localizes a single lysine oxidation
between residues V10 and V68. Although prior depletion of the tryptic peptide 51-56
alludes to oxidation at lysine 56, without further assessment, the specific residue cannot be
concluded. The +15 Da shift on the latter end of the protein indicates presence of both a
+16 Da oxidation and a -1 Da oxidation.
Initially, the top-down CID-IMS experiments only localized modifications between
residues G73 – I112. However, after repeating these experiments with GRT-labelled
oxidized protein, the emergence of an unmodified y51 ion permitted localization of
additional modifications. By covalently binding lysine and possessing an intrinsic charge,
GRT changes both the dissociation energy and pathway, leading to increased fragmentation
in the region proximal to the tag.51 Prior bottom-up MS experiments concluded that K102,
K96 and K56 were suspected of -1 Da oxidation, while a +16 Da modification occurred at
a site between residues 97-118. Combining all available information from bottom-up and
top-down, the lysine oxidation is most likely to be occurring at K102, supported by the
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induced fragmentation pattern by GRT, and observed tryptic peptide drop-out.
Furthermore, the +16 Da modification is localized to residues 96-103, of which Y103 lies
closest to heme and has the highest propensity of oxidation via the TBHP MCO.
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Figure 7: A) Precursor ion selection of control and oxidized Mb, both CS 25+. B) A series
of modelled top down fragments obtained by CID-IM-MS. C) Resultant fragment map,
annotated over the Mb sequence.

2.3.5

Analysis of Protein Dynamics by HDX-MS

After characterization and localization of TBHP-induced oxidative modifications in Mb,
our focus shifted to protein dynamics in order to achieve a better understanding of how
oxidative damage affects the protein behavior.
As outlined earlier, HDX-MS of oxidized proteins presents a level of complexity that
makes this type of experiment difficult, resulting in a scarcity of previous studies on this
topic in literature. For addressing these difficulties, the current work involved extra steps
to ensure proper characterization of covalent modification and also minimize variability of
the sample (i.e., reproducibly achieve complete oxidation while avoiding overoxidation).
HDX-MS software results for oxidized protein were manually scrutinized to assure
accuracy of identified fragments and chemical shifts. Protease inhibition by oxidative
modification again prevented analysis of oxidized peptides. To attain comprehensive
coverage in regions where covalent modifications were previously identified, traces of
residual unmodified peptides were used after rigorous vetting.
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Figure 8: HDX kinetics of Mb peptic peptides, for unmodified control samples (green) and
after TBHP oxidation (red). All points and error bars are derived from 3 replicates.
Peptides marked with an asterisk (*) have 2 replicates for oxidized Mb.
Figure 8 highlights the dynamic differences induced by oxidative stress. All peptides
analyzed from an oxidized protein sample showed a higher deuterium uptake relative to
the control counterpart. In other words, our data indicates enhanced structural dynamics
throughout the protein after oxidation as new intra and intermolecular interactions form as
a result of modified side chains. Covalent modifications may also interrupt or destabilize
certain intramolecular interactions, producing more labile regions. Regions spatially
adjacent to oxidative modifications exhibited the most pronounced uptake differences,
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visible by the deep red colour projected onto the protein structure in Figure 9. The most
affected regions correspond to peptides 30-40 and 87-103/106 (the 87-106 peptide was
only present in the control sample, so the 87-103 peptide is substituted for the modified
sample). Peptides 30-40 and 30-55 lie directly below K102 and Y103, two proposed sites
of oxidation. The large increase in uptake of this region can be attributed to the presence
of modified residues. Similarly, peptide 87-103 contains oxidized residues K102 and Y103,
possibly inducing partial unfolding, resultant in the high deuterium uptake in this region.
Containing the proximal His93, if this peptide is destabilized by the presence of oxidative
damage, binding and interaction with heme may be adversely affected. Covalent
modifications may also be altering adjacent peptide 70-86, as this region possesses a
notable difference between extent of deuteration in control and modified samples.
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Figure 9: Graphic representation of HDX kinetics (from Figure 8).

2.3.6

Oxidation Effects on the Behavior of Electrosprayed Mb Ions
in the Gas Phase

Under gentle experimental conditions, (e.g., temperature, solvent, pH, collision energy)
electrosprayed proteins in the gas phase can maintain solution-like, non-denatured
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conformation. In the native state, a protein is fully folded and functional. Upon oxidation,
the protein loses its native status, as these modifications may promote unfolding or disrupt
intramolecular interactions. Therefore, analysis of gaseous protein ions in this context can
divulge critical information about the detriment of oxidative stress on conformational
dynamics.
The first stage of gas-phase protein analysis involved the assessing the influence of
oxidative damage on folding of the protein using IM-MS (Figure 10). The CCS was
measured for the native 9+ charge state of control Mb, as well as Peaks 1, 2, and 3 of
oxidized Mb. The first measurement was performed under very gentle conditions (i.e., no
collision energy) to obtain a baseline reading. The collision energy was then gradually
increased to assess how the different protein species begin to dynamically unfold in
reaction as a result of higher energy collision with background gas. Since covalent
modification can alter steric and electrostatic interactions, protein structure can either be
destabilized and easily unfold or adopt new, more stable conformations instead. Control
and oxidized species behave relatively similarly until 15 V of trap collision energy, where
all peaks started to shift to a more unfolded state. 17.5 V appears to be a transition point
for the control protein, as it adopts two major conformations – both partially shared with
all three oxidized species. At 20 V trap collision energy, the control protein begins a major
transition to a largely unfolded state – not shared by Peak 1 and 3 of oxidized protein and
only partially shared by Peak 2. As energy continues to increase, no large changes are
observed in Peaks 1 and 3; however, the control has mainly adopted the state with higher
CCS. Peak 2 shares most conformation with Peak 1 and 3, maintaining a small subspecies
that echoes that of the control. These findings suggest that the induction of oxidative stress
on Mb affects its ability to unfold under native conditions, potentially limiting the dynamic
freedom in some domains of the protein.
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Figure 10: Unmodified control and oxidized Mb (Peaks 1, 2, 3) were collisionally activated
by raising the trap collision energy, and changes in CCS were evaluated by IM-MS. The
energy increase caused gradual unfolding of the holo-protein.

Under gentle ESI conditions, unmodified control myoglobin remained bound to its heme
prosthetic group (Figure 11A). A different behavior is seen after TBHP exposure. Figure
11D reveals that upon oxidation, the oxidized protein contains a relatively large fraction of
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apoMb. This data implies that oxidation events destabilize the protein structure and disrupt
coordination of the heme. ApoMb has a higher propensity to unfold than holoMb, and does
not retain function.
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Figure 11: ESI mass spectra of oxidized (red) and control (green) Mb acquired under nondenaturing conditions. (A, D): Full mass spectra. (B, E): Close-up views of the hMb9+
signals. (C, F) hMb9+ signals after precursor selection. The selected ions in panels C and
F were then interrogated by collision-induced dissociation (see subsequent figures).
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To further assess the properties of the holo protein, the native 9+ control and Peaks 1, 2,
and 3 were selectively subjected to increasing amounts of trap collision energy, inducing
dissociation of heme in the gas phase. Figure 12 illustrates this process for control Mb,
showing data for only three of the seven collision energy values. This experiment probes
the stability of the protein in the gas phase and alludes to its overall stability by measuring
propensity to retain heme. On a discontinuous axis (heme on left, m/z 616), Figure 12
shows spectra monitoring the production of free heme+ and subsequent apoMb species.
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Figure 12: Collision-induced dissociation of hMb9+, resulting in the formation of heme+
and apoMb8+. A small fraction of the heme leaves as neutral, generating apoMb9+
product ions. The data shown here illustrate the behavior of an unoxidized control protein
sample.
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Figure 13: Collision induced dissociation of hMb9+ ions into heme+ and apoMb8+ the gas
phase, unmodified control and after TBHP oxidation (Peaks 1,2,3). Relative percentage of
overall signal of heme+ (top plot), holo9+ (middle plot), apo8+ (bottom plot) are plotted as
a function of collision energy.

71

72

Figure 13 graphically summarizes the spectral analysis of the experiment depicted in
Figure 12 - interrogation of the main peaks: heme, hMb9+ and apoMb8+. These graphs show
the change in proportion of overall signal for heme, hMb9+, and apoMb8+ as collision
energy increases. Peaks 1 and 3 start losing their heme already at relatively low levels of
activation, while control Mb lags behind, releasing heme less readily than the oxidized
counterparts. As the collision energy increases, Peaks 1 and 3 most readily deplete the holo
9+ protein, producing apo 8+. Control Mb; however, shows stability through lower
collisional energies and resists the transition until higher energy (50 V) where it rapidly
converts from holo 9+ to apo 8+. Control Mb exhibits the lowest propensity to release
heme, maintaining higher levels hMb instead of early conversion to apoMb like Peaks 1
and 3. These results show that unoxidized Mb exhibits the greatest gas phase stability,
while oxidized protein species release heme readily even at low collision energy. These
data suggest that the interrogation of gaseous protein ions can yield structural and stability
information that is relevant to the behavior of proteins in solution – thereby expanding the
MS toolbox.

2.4

Conclusions

MS provides many different methods for analysis of oxidative modification of protein.
Alone, each individual method may be insufficient, but upon combining information from
the various approaches, a comprehensive picture can be obtained. This data is required for
characterizing covalent modifications and assessing their impact on protein structure and
dynamics. In the context of myoglobin oxidation, TBHP proved to be an effective agent
for obtaining fully oxidized samples. Unlike the previous studies by Imiołek et al.,25 and
Keck24 however, our results clearly demonstrate that TBHP is by no means methionine
specific. One main oxidized species dominates while possessing two prominent
subsidiaries. Often overlooked in prior works, lysine carbonylation to aminoadipic
semialdehyde exists in each of the oxidized species, primarily at K102. The current work
was unable to specifically localize the second lysine oxidation with a high degree of
confidence; however, it provides a narrow range of possible residues. Careful examination
of multiple data sets revealed that Y103 is the predominant site of +16 Da oxidation,
contributing to the main oxidized species (Peak 2). HDX-MS required strenuous sample
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and procedural optimization but provided valuable insight to oxidized protein dynamics.
Regions spatially adjacent to sites of oxidative modification exhibited higher deuterium
uptake, correlating with high mobility and regional unfolding. The high lability of the 87103 peptide indicates possible disruption of the His93-heme coordination. Oxidized Mb
exhibits higher propensity to unfold and lose its heme, although IMS data show that it
adopts a more compact activated structure, relative to its control counterpart. The
combination of reproducible oxidation and various MS analysis methods used provides a
comprehensive workflow for analyzing effects of oxidative stress on proteins, also
highlighting areas of analysis that require closer attention.
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3

Conclusions and Future Work

3.1 Conclusions
An aging population accentuates the importance of understanding pathology of common
ailments. Oxidative damage is a leading cause of cellular disfunction leading to age-related
disease.1–10 This project employed TBHP to oxidize the model protein, myoglobin, to
mimic events of protein oxidative damage, in vitro. The work in this thesis explores
complementary MS methods that can be used to characterize covalent modification by
inducing oxidative damage and assesses the ensuing effect on the dynamics of the protein.
The study highlights the insufficiencies and common obstacles of traditional bottom-up
characterization methods when working with oxidized protein. Inhibition of proteolytic
cleavage and an abundance of false positive hits by proteomics software are two of the
main factors that plague bottom-up analysis of oxidized proteins. Experimental design
should acknowledge these difficulties accordingly before experimenting further or
concluding final results. Top-down analyses are less hindered by protein oxidation,
providing a more robust avenue for the identification of covalent modifications. The
combination of information provided by bottom-up and top-down MS helps achieve
residue-level resolution far better than by each method on its own. With that, covalent
modifications can be confidently identified and localized before proceeding to analyze
protein dynamics.
To comprehensively describe the effects of oxidative damage on protein dynamics, this
work applies a variety of methods including IMS, collision-induced activation (unfolding),
collision induced dissociation (CID) and HDX-MS. HDX-MS has long been revered in
protein dynamic analysis but the significant lack of literature surrounding oxidized proteins
highlights the existing challenges of this methodology. HDX-MS experimentation on
oxidized proteins holds the potential to disseminate intricate impacts on protein dynamics
that lead to protein aggregation and loss of function. This work addresses complications
attributed to sample complexity and accurate peptide mapping to draw conclusions
surrounding the dynamic behavior of oxidized protein.
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This work is intended to highlight the capability of MS in analyzing oxidized protein and
assessing oxidative damage. Oxidative damage plays a central role in various disease
mechanisms, such that understanding which workflows will produce accurate and reliable
results is imperative. Future work can apply the methods used in this project to successfully
study proteins of pathological interest related to common ailments. Myoglobin served as a
model protein for the current study, but a similar experimental design can be applied to any
protein of interest with minor customizations. Gradually increasing the extent of oxidation
on protein systems may also uncover aggregation mechanisms and tendencies. As MS
continues to evolve, the series of techniques used in this project will continue to provide a
comprehensive suite of information.

3.2

Future Work

Lysine oxidation to aminoadipic semialdehyde remains a commonly overlooked covalent
modification due to miniscule m/z differences relative to control samples. Characterization
of these modifications requires instruments with high resolving power and a trained eye.
Development of more robust characterization workflows would help better identify these
modifications and the interactions they cause. One of the lysine modifications on
myoglobin was localized to a small region of amino acids, but we were not able to pinpoint
the exact residue even after the application of multiple proteases and top-down workflows.
Future work should assess and utilize the effectiveness of covalent labelling with fixedcharge molecules on promotion of better fragmentation in top-down MS.11
Currently, no software suite is available to assist in processing results from CID-IM-MS,
resulting in very tedious data analysis; however, manual analysis provides thorough, highconfidence conclusions. Time investment could be largely optimized by development of
software suites to assist users with targeted spectral assessment; however too much reliance
on software to accurately analyze complex protein systems can oversimplify results.
Software results must always be rationalized and verified by users to avoid missing
pertinent data and drawing misled conclusions, as proven in this work.
HDX-MS was successfully applied to probe the altered dynamics of an oxidized protein
system in this work. Future studies are aimed at obtaining better peptide coverage,
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specifically in regions containing covalent modifications. With coverage of oxidized
peptides, the effect of oxidized residues can be probed on neighboring amino acids. This
would provide further insight into oxidative damage dynamics which is currently
unobtainable due to deficiencies in bottom-up workflows. Mixed protease columns may be
considered for future use. Further, with this work demonstrating the merit of HDX-MS on
oxidized proteins, more heavily oxidized protein systems with pathological relevance
should be assessed by the same metrics.
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